Pfizer – Optimizing Maternal Immunization Practice in Canada – RFP

Well-being, Health and Biomedical Discovery


Academic Unit: Inquire within unit

Memorial Deadline: Wednesday 21st, June 2023

External Deadline: Wednesday 28th, June 2023


PLEASE NOTE: Pfizer has extended this opportunity from June 14, 2023 to June 28, 2023

Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the practice gaps as outlined in the specific RFP.

For all independent quality improvement grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, and conduct of the independent initiative supported by the grant. Pfizer must not be involved in any aspect of project development, nor the conduct or monitoring of the quality improvement program.

Date RFP Issued: April 25, 2023

Geographic Scope: Canada

Clinical Area: Vaccines – Maternal Immunization

Link to full RFP: Optimizing Maternal Immunization Practice in Canada

Application Due Date: June 28, 2023

Specific Area of Interest: Potential applicants are encouraged to utilize QI programs to address maternal immunization practice and uptake in areas including but not limited to:

  • Clinical practice to improve the maternal immunization service quality and vaccinations

Novel clinical pathways to optimize vaccination uptake in pregnant women by improving vaccine access in pregnant women

Refer to complete details in the full RFP document. If you have questions regarding this RFP, please direct them in writing to Derek Warnick, Grant Officer (

Funding Sources

Pfizer Inc

This opportunity was posted by: RGCS

Last modified: June 15, 2023